ET Pharma

Goldman Sachs-backed biopharma company Attovia Therapeutics files for US IPO

Jul 18, 2026, 2:21 AM

Translate article text

Choose a language and wait for the translated text.

Founded in 2023, the company develops biologic therapies for immune-mediated diseases using its ATTOBODY platform, with drug candidates targeting inflammatory skin conditions and inflammatory bowel disease.